UPDF AI

Artificial intelligence and the future of life sciences.

M. L. Leite,L. S. de Loiola Costa,4 Authors,Fabrício F. Costa

2021 · DOI: 10.1016/j.drudis.2021.07.002
Drug Discovery Today · 28 Citations

TLDR

This review discusses how AI is starting to revolutionize the life sciences sector and how AI can be used in the development of new drugs or for drug repurposing, in the faster diagnosis and more efficient treatment of various diseases, as well as to design data-driven hypotheses for scientists.

Abstract

Over the past few decades, the number of health and 'omics-related data generated and stored has grown exponentially. Patient information can be collected in real time and explored using various artificial intelligence (AI) tools in clinical trials; mobile devices can also be used to improve aspects of both the diagnosis and treatment of diseases. In addition, AI can be used in the development of new drugs or for drug repurposing, in the faster diagnosis and more efficient treatment of various diseases, as well as to design data-driven hypotheses for scientists. In this review, we discuss how AI is starting to revolutionize the life sciences sector.